HCA Healthcare (NYSE:HCA) SVP Sells $2,020,000.00 in Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Christopher Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

HCA Healthcare Trading Up 0.9%

Shares of HCA opened at $539.91 on Friday. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $552.90. The business’s 50 day moving average is $482.80 and its 200 day moving average is $448.96. The company has a market capitalization of $120.73 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 1.66 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.15%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Norges Bank purchased a new position in HCA Healthcare in the second quarter valued at about $1,152,408,000. Pacer Advisors Inc. raised its stake in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Life Cycle Investment Partners Ltd acquired a new stake in shares of HCA Healthcare in the 4th quarter worth $374,037,000. Viking Global Investors LP boosted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Truist Financial increased their price objective on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a report on Monday, December 15th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Leerink Partners lifted their price target on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $523.27.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.